Quantum computing's potential for drug discovery: Early stage industry dynamics
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Quantum computing (QC) is expected to revolutionize the drug research by performing tasks classical that supercomputers are not capable of. However, practically useful quantum computation is not yet a reality, and thus it is still unclear when and whether QC will be fully capable of solving real-world issues in drug discovery. By identifying the QC-related activities of pharmaceutical companies, startups, and academia in the field of drug discovery and development, we show that QC has gained traction across all of these stakeholder groups, that there is focus on developing utilities related to lead optimization and compound screening, and that there is a need for collaboration in the highly dynamic QC ecosystem. Teaser: Quantum computing could potentially revolutionize {AuQ: Edit OK?} drug discovery and development, but pharmaceutical companies, startups and academia have had different responses to the promise offered by this novel yet immature technology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Quantum Computing in the NISQ era and beyond
Preskill, J. (2018) · Quantum · doi:10.22331/q-2018-08-06-79 · Cited by 8,830
Quantum Computation and Quantum Information: 10th Anniversary Edition
Nielsen, M. A., & Chuang, I. L. (2012) · doi:10.1017/cbo9780511976667 · Cited by 8,436
Quantum supremacy using a programmable superconducting processor
Arute, F., Arya, K., Babbush, R., Bacon, D., Bardin, J. C., Barends, R., Biswas, R., Boixo, S., Brandao, F. G. S. L., Buell, D. A., et al. (2019) · Nature · doi:10.1038/s41586-019-1666-5 · Cited by 7,720
Biamonte, J., Wittek, P., Pancotti, N., Rebentrost, P., Wiebe, N., & Lloyd, S. (2017) · Nature · doi:10.1038/nature23474 · Cited by 4,779
Quantum Algorithm for Linear Systems of Equations
Harrow, A. W., Hassidim, A., & Lloyd, S. (2009) · Physical Review Letters · doi:10.1103/physrevlett.103.150502 · Cited by 3,325
Principles of early drug discovery
Hughes, J., Rees, S., Kalindjian, S., & Philpott, K. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01127.x · Cited by 2,859
Quantum computational advantage using photons
Zhong, H.-S., Wang, H., Deng, Y.-H., Chen, M.-C., Peng, L.-C., Luo, Y.-H., Qin, J., Wu, D., Ding, X., Hu, Y., et al. (2020) · Science · doi:10.1126/science.abe8770 · Cited by 2,405
Quantum Support Vector Machine for Big Data Classification
Rebentrost, P., Mohseni, M., & Lloyd, S. (2014) · Physical Review Letters · doi:10.1103/physrevlett.113.130503 · Cited by 1,951
Artificial intelligence in drug discovery and development
Paul, D., Sanap, G., Shenoy, S., Kalyane, D., Kalia, K., & Tekade, R. K. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2020.10.010 · Cited by 1,695
Albash, T., & Lidar, D. A. (2018) · Reviews of Modern Physics · doi:10.1103/revmodphys.90.015002 · Cited by 1,546
Artificial intelligence in drug development: Present status and future prospects
Mak, K.-K., & Pichika, M. R. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2018.11.014 · Cited by 1,018
Advancing drug discovery via artificial intelligence
Chan, H. C. S., Shan, H., Dahoun, T., Vogel, H., & Yuan, S. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.06.004 · Cited by 654
‘It will change everything’: DeepMind’s AI makes gigantic leap in solving protein structures
Callaway, E. (2020) · Nature · doi:10.1038/d41586-020-03348-4 · Cited by 499
Drug discovery in pharmaceutical industry: productivity challenges and trends
Khanna, I. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.05.007 · Cited by 479
Performance of machine-learning scoring functions in structure-based virtual screening.
Wójcikowski, M., Ballester, P. J., & Siedlecki, P. (2017) · Scientific Reports · doi:10.1038/srep46710 · Cited by 364
Potential of quantum computing for drug discovery
Cao, Y., Romero, J., & Aspuru-Guzik, A. (2018) · IBM Journal of Research and Development · doi:10.1147/jrd.2018.2888987 · Cited by 357
Commercialize quantum technologies in five years
Mohseni, M., Read, P., Neven, H., Boixo, S., Denchev, V., Babbush, R., Fowler, A., Smelyanskiy, V., & Martinis, J. (2017) · Nature · doi:10.1038/543171a · Cited by 268
The prospects of quantum computing in computational molecular biology
Outeiral, C., Strahm, M., Shi, J., Morris, G. M., Benjamin, S. C., & Deane, C. M. (2021) · WIREs Computational Molecular Science · doi:10.1002/wcms.1481 · Cited by 232
Li, R. Y., Di Felice, R., Rohs, R., & Lidar, D. A. (2018) · npj Quantum Information · doi:10.1038/s41534-018-0060-8 · Cited by 202
Quantum computing at the frontiers of biological sciences
Emani, P. S., Warrell, J., Anticevic, A., Bekiranov, S., Gandal, M., McConnell, M. J., Sapiro, G., Aspuru-Guzik, A., Baker, J. T., Bastiani, M., et al. (2021) · Nature Methods · doi:10.1038/s41592-020-01004-3 · Cited by 163
Perdomo, A., Truncik, C., Tubert-Brohman, I., Rose, G., & Aspuru-Guzik, A. (2008) · Physical Review A · doi:10.1103/physreva.78.012320 · Cited by 120
Cited by
Quantum computing for healthcare: a review
Ur Rasool, R., Ahmad, H. F., Rafique, W., Qayyum, A., Qadir, J., & Anwar, Z. (2023) · Future Internet · doi:10.3390/fi15030094 · Cited by 242
Quantum computing for near-term applications in generative chemistry and drug discovery.
Pyrkov, A., Aliper, A., Bezrukov, D., Lin, Y.-C., Polykovskiy, D., Kamya, P., Ren, F., & Zhavoronkov, A. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103675 · Cited by 100
Jang, D., Shin, J., Shim, E., Ohtani, N., & Jeon, O. H. (2024) · Aging Cell · doi:10.1111/acel.14315 · Cited by 84
Insights from incorporating quantum computing into drug design workflows
Lau, B., Emani, P. S., Chapman, J., Yao, L., Lam, T., Merrill, P., Warrell, J., Gerstein, M. B., & Lam, H. Y. K. (2023) · Bioinformatics · doi:10.1093/bioinformatics/btac789 · Cited by 54
Toward the institutionalization of quantum computing in pharmaceutical research
Zinner, M., Dahlhausen, F., Boehme, P., Ehlers, J., Bieske, L., & Fehring, L. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2021.10.006 · Cited by 43
Self-citation
Metadata
- Authors
- Zinner, M., Dahlhausen, F., Boehme, P., Ehlers, J., Bieske, L., & Fehring, L.
- Venue
- Drug Discovery Today
- Publisher
- Elsevier BV
- Published
- 2021-07
- Volume
- 26
- Issue
- 7
- Pages
- 1680-1688
- ISSN
- 1359-6446 (ISSN-L)
- OpenAlex
- W3167544990
- Cited by
- 91
- References
- 21
- FWCI
- 6.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.